Log in to search using one of your social media accounts:

 

Ganglion Cell Loss May Trigger Retinal Problems in Congenital Zika Syndrome Ganglion Cell Loss May Trigger Retinal Problems in Congenital Zika Syndrome
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Ganglion Cyst
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 8, 2017 Category: General Medicine Source Type: news

A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch
Chronic pain and itch are common hypersensitivity syndromes that are affected by endogenous mediators. We applied a systems-based, translational approach to predict, discover, and characterize mediators of pain and itch that are regulated by diet and inflammation. Profiling of tissue-specific precursor abundance and biosynthetic gene expression predicted that inflamed skin would be abundant in four previously unknown 11-hydroxy-epoxy- or 11-keto-epoxy-octadecenoate linoleic acid derivatives and four previously identified 9- or 13-hydroxy-epoxy- or 9- or 13-keto-epoxy-octadecenoate linoleic acid derivatives. All of these me...
Source: Signal Transduction Knowledge Environment - August 22, 2017 Category: Science Authors: Ramsden, C. E., Domenichiello, A. F., Yuan, Z.-X., Sapio, M. R., Keyes, G. S., Mishra, S. K., Gross, J. R., Majchrzak-Hong, S., Zamora, D., Horowitz, M. S., Davis, J. M., Sorokin, A. V., Dey, A., LaPaglia, D. M., Wheeler, J. J., Vasko, M. R., Mehta, N. N. Tags: STKE Research Articles Source Type: news

The transcription factor C/EBP{beta} in the dorsal root ganglion contributes to peripheral nerve trauma-induced nociceptive hypersensitivity
We report that peripheral nerve trauma caused by chronic constriction injury (CCI) increased the abundance of the transcription factor C/EBPβ (CCAAT/enhancer binding protein β) in the DRG. Blocking this increase mitigated the development and maintenance of CCI-induced mechanical, thermal, and cold pain hypersensitivities without affecting basal responses to acute pain and locomotor activity. Conversely, mimicking this increase produced hypersensitivity to mechanical, thermal, or cold pain. In the ipsilateral DRG, C/EBPβ promoted a decrease in the abundance of the voltage-gated potassium channel subunit Kv1.2...
Source: Signal Transduction Knowledge Environment - July 11, 2017 Category: Science Authors: Li, Z., Mao, Y., Liang, L., Wu, S., Yuan, J., Mo, K., Cai, W., Mao, Q., Cao, J., Bekker, A., Zhang, W., Tao, Y.-X. Tags: STKE Research Articles Source Type: news

Ligand- and voltage-gated Ca2+ channels differentially regulate the mode of vesicular neuropeptide release in mammalian sensory neurons
Neuropeptides released from dorsal root ganglion (DRG) neurons play essential roles in the neurotransmission of sensory inputs, including those underlying nociception and pathological pain. Neuropeptides are released from intracellular vesicles through two modes: a partial release mode called "kiss-and-run" (KAR) and a full release mode called "full fusion–like" (FFL). Using total internal reflection fluorescence (TIRF) microscopy, we traced the release of pH-sensitive green fluorescent protein–tagged neuropeptide Y (pHluorin-NPY) from individual dense-core vesicles in the soma and axon of s...
Source: Signal Transduction Knowledge Environment - June 20, 2017 Category: Science Authors: Wang, Y., Wu, Q., Hu, M., Liu, B., Chai, Z., Huang, R., Wang, Y., Xu, H., Zhou, L., Zheng, L., Wang, C., Zhou, Z. Tags: STKE Research Articles Source Type: news

US Army invests $2million in injection to beat PTSD
Numerous military doctors around the world use stellate ganglion block injections to 'reset' the nervous system in soldiers tormented by past trauma. Now the Pentagon is backing US research on it. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2017 Category: Consumer Health News Source Type: news

Regenerating optic pathways from the eye to the brain
Humans are highly visual. Retinal ganglion cells (RGCs), the neurons that connect the eyes to the brain, fail to regenerate after damage, eventually leading to blindness. Here, we review research on regeneration and repair of the optic system. Intrinsic developmental growth programs can be reactivated in RGCs, neural activity can enhance RGC regeneration, and functional reformation of eye-to-brain connections is possible, even in the adult brain. Transplantation and gene therapy may serve to replace or resurrect dead or injured retinal neurons. Retinal prosthetics that can restore vision in animal models may too have pract...
Source: ScienceNOW - June 8, 2017 Category: Science Authors: Laha, B., Stafford, B. K., Huberman, A. D. Tags: Neuroscience special/review Source Type: news

Pain and Spine Clinics Now Offering Effective PTSD Treatment with...
Pain and Spine Clinics is now offering effective PTSD treatment with stellate ganglion blocks. The outpatient procedure has been shown to be extremely effective for relieving the symptoms of PTSD for...(PRWeb April 24, 2017)Read the full story at http://www.prweb.com/releases/PTSD-treatment/phoenix-arizona/prweb14256071.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 24, 2017 Category: Pharmaceuticals Source Type: news

Helping the retina regenerate
A new report gives recommendations for regenerating retinal ganglion cells (RGCs), crucial neurons in the back of the eye that carry visual information to the brain. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 31, 2017 Category: Science Source Type: news

Helping the retina regenerate
A new report gives recommendations for regenerating retinal ganglion cells (RGCs), crucial neurons in the back of the eye that carry visual information to the brain. Authored by Monica Vetter, Ph.D., University of Utah, and Peter Hitchcock, Ph.D., University of Michigan, the report stems from a 2016 workshop sponsored by the National Eye Institute (NEI) Audacious Goals Initiative  (AGI). (Source: News from NEI)
Source: News from NEI - March 30, 2017 Category: Opthalmology Authors: haysdc Source Type: news

Minimally-invasive migraine treatment for adults works on kids, too
[Image from Tagosaku on Flickr]Migraine treatment that has been safe for adults has recently proven to be safe for use in children as well. The minimally-invasive treatment only takes a few minutes for children and teenagers to be able to feel the effects. The treatment involves a sphenopalatine ganglion (SPG) block that does not need needles. It uses a small, flexible catheter that is put into each nostril that delivers a local anesthetic to the SPG, which has often been considered the nerve bundle that causes migraines, that is in the back of the nose. The treatment disables the SPG and resets the headache circuit, reduc...
Source: Mass Device - March 13, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Pain Management MedTech migraines Phoenix Children's Hospital radiology Source Type: news

Retinal Degeneration Ongoing in Pediatric MS Retinal Degeneration Ongoing in Pediatric MS
Children with multiple sclerosis showed more progressive ganglion cell layer thinning than healthy kids or those with monophasic demyelination -- and there was more retinal atrophy in girls than in boys.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 1, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

[Perspective] Relief for retinal neurons under pressure
Advancing age predisposes us to a number of neurodegenerative diseases, yet the underlying mechanisms are poorly understood. With some 70 million individuals affected, glaucoma is the world's leading cause of irreversible blindness. Glaucoma is characterized by the selective loss of retinal ganglion cells that convey visual messages from the photoreceptive retina to the brain. Age is a major risk factor for glaucoma, with disease incidence increasing near exponentially with increasing age. Treatments that specifically target retinal ganglion cells or the effects of aging on glaucoma susceptibility are currently lacking. On...
Source: ScienceNOW - February 16, 2017 Category: Science Authors: Jonathan Crowston Tags: Neurodegenerative Disease Source Type: news

Stem cell secretions may protect against glaucoma
NEI scientists find that stem cell exosomes promote survival of retinal ganglion cells in rats. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 27, 2017 Category: American Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for January 18, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Allergan pays $15m for failing to disclose Actavis ‘white knight’ offer The SEC said yesterday that Allergan will pay a $15 million fine for failing to disclose its 2014 merger talks with Actavis. In June 2014, Vale...
Source: Mass Device - January 18, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Abbott launches dorsal root ganglion neurostim system in Europe
Abbott (NYSE:ABT) said today that it launched its Proclaim dorsal root ganglion neurostimulation system in Europe for patients suffering from chronic neuropathic pain. The Abbott Park, Il.-based company’s system targets sensory nerves packed within the dorsal root ganglion to directly target the area of the body where pain occurs and provide stronger pain relief compared to traditional spinal cord stimulation therapy. “Many patients battling chronic neuropathic pain have not found adequate relief from other forms of treatment, which is why dorsal root ganglion stimulation has been such an important therapeutic ...
Source: Mass Device - January 18, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Neuromodulation/Neurostimulation Pain Management Regulatory/Clearance Wall Street Beat Abbott Source Type: news

MassDevice.com +5 | The top 5 medtech stories for January 17, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA warns again on Pentax duodenoscopes The FDA issued a statement today warning that Hoya subsidiary Pentax Medical’s ED-3490TK video duodenoscopes have a potential risk associated with the design and manufacturing of th...
Source: Mass Device - January 17, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Abbott touts dorsal root ganglion stim study
Abbott (NYSE:ABT) today touted short- and long-term data published in the journal Pain, which demonstrated that its dorsal root ganglion stimulation therapy benefits patients suffering from complex regional pain syndrome more than traditional spinal cord stimulation. The Abbott Park, Ill.-based company said it’s the only company in the world approved to offer DRG stimulation. The newly-published data is from the company’s ACCURATE study, which evaluated DRG stimulation in patients for 3 and 12 months. “Historically, many patients with chronic pain resulting from complex regional pain syndrome or...
Source: Mass Device - January 17, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Pain Management Research & Development Spinal Abbott Source Type: news

New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success over Traditional Spinal Cord Stimulation
ACCURATE STUDY CONFIRMS DRG STIMULATION PROVIDES SUPERIOR, TARGETED AND CONSISTENT PAIN RELIEF FOR PATIENTS WITH COMPLEX REGIONAL PAIN SYNDROME (Source: Abbott.com)
Source: Abbott.com - January 17, 2017 Category: Pharmaceuticals Source Type: news

Habitual Cannabis Use May Slow Visual Perception Habitual Cannabis Use May Slow Visual Perception
An electrophysiology study of retinal cell function finds altered processing with substantial delay in the transmission of action potentials by the ganglion cells in regular cannabis users.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2016 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

French study suggests Cannabis 'affects your eyesight'
A small study in France has found prolonged marijuana use could wear down retinal ganglion cells, the nerves that sit just behind the retina. (Source: the Mail online | Health)
Source: the Mail online | Health - December 8, 2016 Category: Consumer Health News Source Type: news

OCT for Tracking Glaucoma Progression OCT for Tracking Glaucoma Progression
Researchers hypothesized that the macular ganglion cell layer would prove a more advantageous measure of glaucoma progression, but their results indicated otherwise.Medscape Ophthalmology (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - November 14, 2016 Category: Opthalmology Tags: Ophthalmology Viewpoint Source Type: news

Vancouver man with recurring cyst pops the lump with a fish hook and push pin
Jason, from Vancouver, has been battling this recurring ganglion cyst for years. But now, he thinks he has found the fail-safe solution: a humble push pin. (Source: the Mail online | Health)
Source: the Mail online | Health - September 21, 2016 Category: Consumer Health News Source Type: news

Exercise reverses age-related vulnerability of the retina to injury by preventing complement-mediated synapse elimination via a BDNF-dependent pathway - Chrysostomou V, Galic S, van Wijngaarden P, Trounce IA, Steinberg GR, Crowston JG.
Retinal ganglion cells (RGCs) become increasingly vulnerable to injury with advancing age. We recently showed that this vulnerability can be strongly modified in mice by exercise. However, the characteristics and underlying mechanisms of retinal protection... (Source: SafetyLit)
Source: SafetyLit - September 14, 2016 Category: Global & Universal Tags: Age: Elder Adults Source Type: news

What Causes Hyperphosphatemia?
Discussion Constipation is a common problem in general pediatrics and its causes are numerous. It can cause acute and recurrent abdominal pain and is a cause of abdominal distention. Patients who are young, whose presentations are other than routine or who had complications should be invested for underlying causes of their constipation. This patient had undergone some evaluations in the past for constipation but because of the presentation of sepsis a more rigorous evaluation was undertaken. The differential diagnoses of the following can be found here: constipation, acute abdominal pain, recurrent abdominal pain, and abdo...
Source: PediatricEducation.org - September 12, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Ganglion
Title: GanglionCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/23/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 23, 2016 Category: Rheumatology Source Type: news

Blue and red light-evoked pupil responses in photophobic subjects with TBI - Yuhas PT, Shorter PD, McDaniel CE, Earley MJ, Hartwick AT.
PURPOSE: Photophobia is a common symptom in individuals suffering from traumatic brain injury (TBI). Recent evidence has implicated blue light-sensitive intrinsically photosensitive retinal ganglion cells (ipRGCs) in contributing to the neural circuitry me... (Source: SafetyLit)
Source: SafetyLit - August 7, 2016 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Characterization of ion channels on subesophageal ganglion neurons from Chinese tarantula Ornithoctonus huwena: exploring the myth of the spider insensitive to its venom - Deng M, Hu Z, Cai T, Liu K, Wu W, Luo X, Jiang L, Wang M, Yang J, Xiao Y, Liang S.
In this study, using whole-cell patch-clamp technique we investigated electrophysiological and pharmacological properties of ion c... (Source: SafetyLit)
Source: SafetyLit - July 29, 2016 Category: Global & Universal Tags: Non-Human Animals and Insects Source Type: news

Use it or Lose it: Visual Activity Regenerates Neural Connections Between Eye and Brain
A study in mice funded by the National Institutes of Health (NIH) shows for the first time that high-contrast visual stimulation can help damaged retinal neurons regrow optic nerve fibers, otherwise known as retinal ganglion cell axons. In combination with chemically induced neural stimulation, axons grew further than in strategies tried previously. Treated mice partially regained visual function. The study also demonstrates that adult regenerated central nervous system (CNS) axons are capable of navigating to correct targets in the brain. Language English (Source: News from NEI)
Source: News from NEI - July 8, 2016 Category: Opthalmology Authors: Jason Source Type: news

New data propel headache neuromodulation devices toward approval
WASHINGTON – Encouraging data on an external vagal nerve stimulator and a minimally invasive system that targets the sphenopalatine ganglion are propelling the two neuromodulation devices toward... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 7, 2016 Category: Neurology Source Type: news

New data propel headache neuromodulation devices toward approval
WASHINGTON – Encouraging data on an external vagal nerve stimulator and a minimally invasive system that targets the sphenopalatine ganglion are propelling the two neuromodulation devices toward... (Source: Family Practice News)
Source: Family Practice News - July 7, 2016 Category: Primary Care Source Type: news

Eye Strain Caused by Digital Screens
I’ve noticed a frightening trend occurring around the world. Instances of eye problems are increasing with rapid numbers. Problems like myopia – once thought to be genetic – are going up exponentially with each passing year. Many eye diseases have no early symptoms. You may not see a change in your vision until the disease has become advanced. Are Eye Problems Genetic? We have to look at the bigger picture here… eye problems aren’t always genetic, and there are changes in our environment that are having a negative impact on our eyesight. Serious Eye Problems That Affects Your Vision One area ...
Source: Al Sears, MD Natural Remedies - June 24, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news

What is a Ganglion Cyst?
Discussion Lumps and bumps in the pediatric age group are most often benign. They can be from unwitnessed/unrecognized trauma (e.g. leg bruise, Osgood-Schlater disease, insect bites), normal pubertal changes (e.g. gynecomastia, testicular enlargement, acne) or normal variants (e.g. prominence of mastoid or occipital process). Some are often uncomplicated but need appropriate treatment (e.g. early abscess formation, inguinal hernia, dermoid cyst). Prominent lymph nodes are a very common reason for parents to come to the physician. Patients and families are often distressed by these masses and seek help because “they ...
Source: PediatricEducation.org - May 16, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

St. Jude Medical Announces US Launch And First Commercial Implants Of DRG Stimulation Therapy
St. Jude Medical, Inc., a global medical device company, recently announced the U.S. launch and first post-approval implants of the St. Jude Medical AxiumNeurostimulator System for dorsal root ganglion (DRG) stimulation to treat patients with chronic pain that has been hard to control with traditional spinal cord stimulation (SCS). (Source: Medical Design Online News)
Source: Medical Design Online News - April 12, 2016 Category: Medical Equipment Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 11, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Grifols puts up $100m for a 49% stake in Interstate Blood Bank Grifols said that it agreed to pay $100 million for a 49% stake in plasma collector Interstate Blood Bank. The deal includes an option to buy the remaining 51% for ...
Source: Mass Device - April 11, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

St. Jude Medical’s Axium chronic pain device makes its U.S. debut
St. Jude Medical (NYSE:STJ) today announced the U.S. debut of its Axium neurostimulator system, after the device won FDA approval in February for treating chronic pain. The 1st patients were implanted in West Virginia and California with the Axium device, which uses dorsal root ganglion stimulation to treat moderate to severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome, St. Jude said. The Axium is slated to be implanted in 25 states in the coming weeks, with 100 procedures due in the 1st month after launch, the Little Canada,...
Source: Mass Device - April 11, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Pain Management Wall Street Beat St. Jude Medical Source Type: news

St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy
Availability of the dorsal root ganglion (DRG) therapy represents an important milestone in the treatment of chronic intractable pain conditions due to complex regional pain syndrome I and II ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. ... Devices, Neurology, Product LaunchSt. Jude Medical, dorsal root ganglion, Axium , Neurostimulator, DRG therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2016 Category: Pharmaceuticals Source Type: news

Medical News Today: Glaucoma treatment expected to improve with new stem cell method
By devising a way to produce retinal ganglion cells from stem cells derived from individual patients, researchers hope to improve personalized treatments for glaucoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 23, 2016 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

Ganglion Block Beats Blood Patch for Dural Puncture HeadacheGanglion Block Beats Blood Patch for Dural Puncture Headache
This approach should be the first-line therapy for obstetric patients experiencing postdural puncture headache, researchers say. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 23, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

St. Jude Gains FDA Approval For Cardiac Pacing, Neurostimulation Technologies
The FDA has approved two new technologies that expand St. Jude Medical’s portfolio for cardiac resynchronization therapy (CRT) and neurostimulation in the U.S. market. St. Jude announced that its MultiPoint Pacing (MPP) technology would be added to the company’s Quadra CRT device offerings in the beginning of 2016, and that the Axium Neurostimulator System was approved for dorsal root ganglion (DRG) stimulation for patients with chronic pain in their lower limbs. (Source: Medical Design Online News)
Source: Medical Design Online News - February 18, 2016 Category: Medical Equipment Source Type: news

St. Jude wins FDA green light for Axium chronic pain device
St. Jude Medical (NYSE:STJ) said today it won FDA premarket approval for its Axium neurostimulator system using dorsal root ganglion stimulation. The device from St. Paul, Minn.-based St. Jude is designed to treat moderate to severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome. “The approval of St. Jude Medical’s DRG neurostimulation system represents an exciting new option for me to deploy in the fight against the focal and intractable chronic pain syndromes facing my patients every day. For the large and growing numbers of under-treated patients s...
Source: Mass Device - February 17, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological Neuromodulation/Neurostimulation St. Jude Medical Source Type: news

Video shows man popping a large ganglion cyst on his arm with a PIN
WARNING: GRAPHIC CONTENT. The man, known only as Jason, from Vancouver, cries in pain as he hammers the pin into his ganglion cyst. Reams of clear, sticky jelly ooze out. (Source: the Mail online | Health)
Source: the Mail online | Health - January 11, 2016 Category: Consumer Health News Source Type: news

Quantifying Spiral Ganglion Neurite and Schwann Behavior on Micropatterned Polymer Substrates
The first successful in vitro experiments on the cochlea were conducted in 1928 by Honor Fell (Fell, Arch Exp Zellforsch 7(1):69–81, 1928). Since then, techniques for culture of this tissue have been refined, and dissociated primary culture of the spiral ganglion has become a widely accepted in vitro model for studying nerve damage and regeneration in the cochlea. Additionally, patterned substrates have been developed that facilitate and direct neural outgrowth. A number of automated and semi-automated methods for quantifying this neurite outgrowth have been utilized in recent years (Zhang et al., J Neurosci Methods ...
Source: Springer protocols feed by Molecular Medicine - January 1, 2016 Category: Molecular Biology Source Type: news

Retinal nerve cells grown in the lab
A method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain, has been discovered by researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 30, 2015 Category: Science Source Type: news

Researchers grow retinal nerve cells in the lab
(Johns Hopkins Medicine) Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 30, 2015 Category: Global & Universal Source Type: news

Neuron Astrocyte Glial Markers
Potent and Frequently Published!We have a stout catalog of Neuron-Astrocyte and Glial Markers.They are widely used and frequently published. Here're some recent examples:Mouse Monoclonal GFAP: Chelsea M. Larabee, Constantin Georgescu, Jonathan D. Wren and Scott M. Plafke. Expression profiling of the ubiquitin conjugating enzyme UbcM2 in murine brain reveals modest age-dependent decreases in specific neurons. BMC Neuroscience201516:76 DOI: 10.1186/s12868-015-0194-y© Larabee et al. 2015.Image: Mixed neuron-glial cultures stained with Mouse Monoclonal GFAP, and Chicken Polyclonal Neurofilament-NF-L (green). The GFAP anti...
Source: Neuromics - November 28, 2015 Category: Neuroscience Tags: Astrocyte-Glial-Neuron Co-cultures GFAP Antibody Immunfluorescence immunoblotting Immunohistochemistry Neurofilament Markers Neuron Markers Source Type: news

Staining Neurons and 3-D
In this study researchers use our Tuj-1/Beta Tubulin Antibody to stain neurons in 3-D Cultures: Gaoying Sun, Wenwen Liu, Zhaomin Fan, Daogong Zhang, Yuechen Han, Lei Xu1, Jieyu Qi, Shasha Zhang, Bradley T. Gao, Xiaohui Bai,Jianfeng Li,Renjie Chai, Haibo Wang. The three-dimensional culture system with matrigel and neurotrophic factors preserves the structure and function of spiral ganglion neuron in vitro...Tuj-1-β-tubulin (1:1000, Neuromics, USA)... Images: Morphology of the SGNs growth cone cultured in 2D and 3D systems. Phalloidin, green; β-tubulin, red.I will continue to post positive developments concerning u...
Source: Neuromics - November 20, 2015 Category: Neuroscience Tags: 3-D Cell based Assays 3-D Cell Culturing Immunofluorescence Neurons Tuj 1 (Neuron-specific class III beta-tubulin) antibody Tuj 1 antibody Tuj-1 antibodies Source Type: news

Subretinal Implant Restores Sight in Retinitis PigmentosaSubretinal Implant Restores Sight in Retinitis Pigmentosa
Almost three-quarters of patients blinded by retinitis pigmentosa were able to localize or identify objects after receiving a subretinal implant that stimulates ganglion cells. Medscape Medical News (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - November 19, 2015 Category: Opthalmology Tags: Ophthalmology News Source Type: news

Capstone Pain and Spine Now Offering Over Ten Effective Migraine...
Top Dallas pain clinic, Capstone Pain and Spine, is now offering over ten effective migraine therapies. New options include occipital blocks and sphenopalatine ganglion blocks.(PRWeb November 16, 2015)Read the full story at http://www.prweb.com/releases/migrain-specialist/dallas-fort-worth-texas/prweb13081048.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 16, 2015 Category: Pharmaceuticals Source Type: news

Arizona Injury Medical Associates PLLC Now Offering Ganglion Impar...
Arizona Injury Medical Associates PLLC is now offering ganglion impar blocks for those suffering from tailbone and pelvic pain. The procedure is performed by a Double Board Certified physician at the...(PRWeb October 05, 2015)Read the full story at http://www.prweb.com/releases/arizona-injury-medical/ganglion-impar-block/prweb12980792.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2015 Category: Pharmaceuticals Source Type: news